Diabetes Mellitus
Acute coronary syndrome in the past 6 months
Cardiac arrhythmias (2nd and 3rd degree heart block or premature ventricular complexes in Lown classes 4 or 5)
Symptoms suggestive of obstructive or central sleep apnea (with a score of > 10 on Epworth sleepiness scale)
Patients taking Clonidine
Body mass index (BMI) > 34
Patients unable to give consent
Pregnant women
Patients with leg injury involving nerve damage
Patients taking anticoagulant medication
Patients with significant bleeding disorder or liver disorder
Hemoglobin <1.05 g/dl at the time of initiation of therapy
patients with unilateral or bilateral nephrectomy
Planned kidney transplant in the next 4 months
Life expectancy under 6 months
Oliguria (urine output less than 400 ml per day)

NCT01228279_exc_T1
Condition
Diabetes Mellitus
NCT01228279_exc_T2
Condition
Acute coronary syndrome
NCT01228279_exc_T3
Temporal
in the past 6 months
NCT01228279_exc_T4
Condition
Cardiac arrhythmia
NCT01228279_exc_T5
Condition
3rd degree heart block
NCT01228279_exc_T6
Condition
d a gree heart block o
NCT01228279_exc_T7
Condition
premature ventricular complexes
NCT01228279_exc_T8
Qualifier
Lown classes 4
NCT01228279_exc_T9
Qualifier
wn classes 4
NCT01228279_exc_T10
Scope
Lown classes 4 or 5
NCT01228279_exc_T11
Scope
(2nd and 3rd degree heart block or premature ventricular complexes in Lown classes 4 or 5)
NCT01228279_exc_T12
Condition
tructive or ep apnea (w
NCT01228279_exc_T13
Condition
central sleep apnea
NCT01228279_exc_T14
Measurement
Epworth sleepiness scale
NCT01228279_exc_T15
Value
score of > 10
NCT01228279_exc_T17
Scope
obstructive or central sleep apnea
NCT01228279_exc_T16
Drug
Clonidine
NCT01228279_exc_T18
Measurement
Body mass index
NCT01228279_exc_T19
Measurement
BMI
NCT01228279_exc_T20
Value
> 34
NCT01228279_exc_T23
Condition
leg injury
NCT01228279_exc_T24
Condition
nerve damage
NCT01228279_exc_T25
Drug
anticoagulant
NCT01228279_exc_T26
Condition
bleeding disorder
NCT01228279_exc_T27
Condition
liver disorder
NCT01228279_exc_T28
Qualifier
significant
NCT01228279_exc_T29
Measurement
Hemoglobin
NCT01228279_exc_T30
Value
<1.05 g/dl
NCT01228279_exc_T31
Temporal
at the time of initiation of therapy
NCT01228279_exc_T32
Reference_point
initiation of therapy
NCT01228279_exc_T33
Procedure
nephrectomy
NCT01228279_exc_T34
Qualifier
bilateral
NCT01228279_exc_T35
Qualifier
unilateral
NCT01228279_exc_T36
Scope
unilateral or bilateral
NCT01228279_exc_T37
Condition
kidney transplant
NCT01228279_exc_T38
Qualifier
Planned
NCT01228279_exc_T39
Temporal
in the next 4 months
NCT01228279_exc_T40
Observation
Life expectancy
NCT01228279_exc_T41
Value
under 6 months
NCT01228279_exc_T42
Condition
Oliguria
NCT01228279_exc_T43
Measurement
urine output
NCT01228279_exc_T44
Value
less than 400 ml per day